Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Meller

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Cancer|March 15, 1997
High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservationM Gutman, M Inbar, D Lev-Shlush, et al.
Cancer|April 3, 2001
Multiple primary malignancies in association with soft tissue sarcomasO Merimsky, Y Kollender, J Issakov, et al.
The British Journal of Radiology|May 28, 2013
Hypofractionated adjuvant radiation therapy of soft-tissue sarcoma achieves excellent results in elderly patientsV Soyfer, B W Corn, Y Kollender, et al.
Harefuah|October 1, 1996
[Isolated limb perfusion with tumor necrosis factor for malignancies of the limbs]S Abu-Abid, M Gutman, D Lev, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|February 11, 2014
The role of the fibula head flap for joint reconstruction after osteoarticular resectionsM F Scaglioni, E I Chang, E Gur, et al.
Oncology Reports|November 6, 2007
Synovial sarcoma of the extremities and trunk: a long-lasting diseaseA Gofman, J Issakov, Y Kollender, et al.
Pediatric Blood & Cancer|January 26, 2007
Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcomaM Weyl Ben Arush, O Israel, S Postovsky, et al.
Surgery|November 24, 1999
Limb desmoid tumors: a possible role for isolated limb perfusion with tumor necrosis factor-alpha and melphalanD Lev-Chelouche, S Abu-Abeid, R Nakache, et al.
Oncology|January 11, 2001
Is forequarter amputation justified for palliation of intractable cancer symptoms?O Merimsky, Y Kollender, M Inbar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
Association between telomerase activity and outcome in patients with nonmetastatic Ewing family of tumorsA Ohali, S Avigad, I J Cohen, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Cancer|March 15, 1997
High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservationM Gutman, M Inbar, D Lev-Shlush, et al.
Cancer|April 3, 2001
Multiple primary malignancies in association with soft tissue sarcomasO Merimsky, Y Kollender, J Issakov, et al.
The British Journal of Radiology|May 28, 2013
Hypofractionated adjuvant radiation therapy of soft-tissue sarcoma achieves excellent results in elderly patientsV Soyfer, B W Corn, Y Kollender, et al.
Harefuah|October 1, 1996
[Isolated limb perfusion with tumor necrosis factor for malignancies of the limbs]S Abu-Abid, M Gutman, D Lev, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|February 11, 2014
The role of the fibula head flap for joint reconstruction after osteoarticular resectionsM F Scaglioni, E I Chang, E Gur, et al.
Oncology Reports|November 6, 2007
Synovial sarcoma of the extremities and trunk: a long-lasting diseaseA Gofman, J Issakov, Y Kollender, et al.
Pediatric Blood & Cancer|January 26, 2007
Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcomaM Weyl Ben Arush, O Israel, S Postovsky, et al.
Surgery|November 24, 1999
Limb desmoid tumors: a possible role for isolated limb perfusion with tumor necrosis factor-alpha and melphalanD Lev-Chelouche, S Abu-Abeid, R Nakache, et al.
Oncology|January 11, 2001
Is forequarter amputation justified for palliation of intractable cancer symptoms?O Merimsky, Y Kollender, M Inbar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
Association between telomerase activity and outcome in patients with nonmetastatic Ewing family of tumorsA Ohali, S Avigad, I J Cohen, et al.
Pageof 9